Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder

Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder

Abstract Aim Atomoxetine (ATX) is a non‐central stimulant and a standard treatment for adult attention‐deficit/hyperactivity disorder (ADHD). The long‐term efficacy of Atomoxetine is about 40% at 6 months. The variability in efficacy between individuals is thought to be related to patient‐specific f...

Full description

Bibliographic Details
Main Authors: Tsutomu Nagai, Tatsuya Kurihara, Hiroaki Koya, Yukako Nakano, Satoru Sugisawa, Takehiko Sambe, Keiko Kishimoto, Mari Kogo, Haruhisa Ota, Akira Iwanami, Naoki Uchida
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Neuropsychopharmacology Reports
Subjects:
adrenergic uptake inhibitors
atomoxetine hydrochloride
attention‐deficit disorder with hyperactivity
cohort studies
multivariate analysis
Online Access:https://doi.org/10.1002/npr2.12253

Internet

https://doi.org/10.1002/npr2.12253

Similar Items